News

$385 million Centre for Obesity, Diabetes and Cardiovascular Disease


12 December 2008

The Australian Government pledged $95 million for the University of Sydney's Centre for Obesity, Diabetes and Cardiovascular Disease through its Higher Education Endowment Fund today.

The Faculty of Science is a key partner in the new $385 million Centre for Obesity, Diabetes and Cardiovascular Disease.
The Faculty of Science is a key partner in the new $385 million Centre for Obesity, Diabetes and Cardiovascular Disease.

The $385 million Centre for Obesity, Diabetes and Cardiovascular Disease, to be built by 2013, will house close to 100 research groups, enabling them to maximise research potential and creating Australia's single largest clinical trials capacity.

The key partners in the Centre will be the University's faculties of Science, Health and Engineering - including its new Institute of Obesity, Nutrition and Exercise, and the NHMRC Clinical Trials Centre - as well as Sydney medical institutes including the Centenary, Bosch, Heart Research, George and Woolcock Institutes and the Sydney South West Area Health Service.

The Centre will conduct internationally significant research, partnering with prestigious institutions in USA, Europe and Asia, and attracting hundreds of world-class clinicians and researchers to Sydney.

Importantly, the Centre will engage in translational research - where basic scientific discoveries will be progressed through to new and fundamental advances in treatments and prevention to influence clinical practice and public health policy throughout Australia and Asia.

The Centre will be located on land acquired by the University of Sydney in 2007, adjacent to the Camperdown campus and the Royal Prince Alfred Hospital. This land will be used to create a major international biomedical precinct, as part of its broad strategy to expand biomedical and life sciences.

"The Centre for Obesity, Diabetes and Cardiovascular Disease represents the first development in the University of Sydney's plans to create a major international biomedical research and training precinct," said Dr Michael Spence, Vice-Chancellor of the University of Sydney.

"This precinct will progressively accommodate more than 5 000 researchers and postgraduate students and become one of the world's most intense concentrations of national and international research leaders and partners in health and related fields."

The Centre for Obesity, Diabetes and Cardiovascular Disease will be one of the world's first centres to conduct thematic research on the connectivity between obesity, diabetes and cardiovascular disease. It will also become one of the first centres dedicated to these inter-related diseases capable of translational research due to its housing of hundreds of specialists of diverse academic backgrounds in the one institution.

The Centre will house high quality facilities for teaching and learning in pharmacology, physiology, medicinal chemistry and other areas of focus, allowing an expansion of undergraduate student numbers in these areas by as much as 50 per cent, due to larger, more efficient teaching spaces.

With the development of the new Centre the University aims to recruit top-quality research students with the goal of doubling the number of PhD students per staff member to reach the levels in leading US and European institutions.


Contact: Katynna Gill

Phone: 02 9351 6997

Email: 52251f03291d15422d2b5454331930204b7f2c0b251a2b00